Prelude Capital Management’s Daxor DXR Stock Holding History

Prelude Capital Management’s Portfolio DXR Stock Details DXR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-7,686	Closed	-$104K	–	2023
2020 Q1	$104K	Buy	7,686 +591	+8%	+$6.11K	0.01%	579
2019 Q4	$67K	Sell	7,095 -1,923	-21%	-$18.2K	﹤0.01%	1243
2019 Q3	$87K	Sell	9,018 -12,155	-57%	-$109K	﹤0.01%	998
2019 Q2	$168K	Buy	21,173 +2,074	+11%	+$19.1K	0.01%	792
2019 Q1	$215K	Buy	19,099 +18,942	+12,065%	+$283K	0.01%	691
2018 Q4	$1K	Buy	+157	New	+$1.02K	﹤0.01%	1711

Other funds holding DXR

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Prelude Capital Management's DXR Position: Q2 2020 in Review

Prelude Capital Management sold out of Daxor (DXR) in Q2 2020, closing a stake of 7,686 shares — an estimated $104K sold.

Prelude Capital Management first reported a position in DXR in Q4 2018 and held it in 6 quarters. The position peaked at $215K in Q1 2019. 3 funds tracked by Wall St. Rank hold DXR as of Q2 2020.

Prelude Capital Management reported no remaining Daxor position as of Q2 2020 after selling out during the quarter.
Prelude Capital Management sold 7,686 Daxor shares in Q2 2020, an estimated $104K.
Prelude Capital Management first reported a position in Daxor in Q4 2018 and held it in 6 quarters.
Prelude Capital Management's Daxor position peaked at $215K in Q1 2019.
3 funds tracked by Wall St. Rank held Daxor as of Q2 2020.

Based on Prelude Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.